CD86 and diffuse large B-cell lymphoma: In line with the in silico results, the number of mTOR+ CD86+ cells was significantly lower in the intra-T than peri-T area (276.2 ± 75.0 vs 383.8 ± 100.4, p = 4e-04) and was higher in DLBCL than control samples (660.1 ± 154.7 vs 2 94.5 ± 78.3, p = 8e-06) (Figure 5E).